Sort
82,697 grants matching “vaccine development”
Center for Advancing Equity in Clinical Preventive Services
$1,368,334David W. Baker · Northwestern University At Chicago · P01 · FY2011 · HS
Pre-clinical Vaccine and Antibody Development for Coronavirus Disease 2019 (COVID-19)
$1,368,169Wing Pui Kong · National Institute Of Allergy And Infectious Diseases · ZIC · FY2024 · AI
Role of Inducible Bronchus Associated Lymphoid Tissue in Latent Tuberculosis
$1,368,144Shabaana A. Khader · University Of Chicago · R01 · FY2025 · AI
Role of Inducible Bronchus Associated Lymphoid Tissue in Latent Tuberculosis
$1,368,144Shabaana A. Khader · University Of Chicago · R01 · FY2024 · AI
Improving the Outcome of Patients with Chronic Myeloid Leukemia Through Medi
$1,367,891Jorge E Cortes · University Of Tx Md Anderson Can Ctr · P01 · FY2012 · CA
Under Pressure: Biophysical Mapping of Herpesvirus Capsid Assembly and Genome Packaging
$1,367,863Elizabeth Bennett Draganova · Emory University · DP2 · FY2023 · GM
CoVPN Cross-Protocol Analyses
$1,367,342Peter B. Gilbert · Fred Hutchinson Cancer Research Center · UM1 · FY2021 · AI
ZIMBABWE--COMMUNITY INTERVENTION TO REDUCE HIV/STD RISK
$1,366,806Battelle Centers/Pub Hlth Res &Evaluatn · U10 · FY2003 · MH
Immunology Quality Assessment Program
$1,366,716Mollie Sykes · Duke University · N01 · FY2011 · AI
SBIR Phase II: A Novel Bacteriophage Mutant as a Platform Carrier for Next Generation Vaccines
$1,366,595Herbert W Kavunja · Iaso Therapeutics, Inc. · · FY2022 · TIP
Antibody Neutralization Mechanisms
$1,366,331Tongqing Zhou · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Task V05: Manufacture of E. Coli Master Cell Banks for Staphylococcus aureus
$1,366,000Andreas Neubert · Idt Biologika Gmbh · N01 · FY2019 · AI
Preclinical development of a TriCoil-based nicotine vaccine
$1,365,834Christopher H Clegg · Tria Bioscience Corporation · UH3 · FY2019 · DA
Epitope-focused vaccine strategies against Zika virus
$1,365,131Michel C Nussenzweig · Rockefeller University · P01 · FY2018 · AI
Mali International Center for Excellence in Research: Malaria immunology
$1,365,044Susan Pierce · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Preclinical development of a TriCoil-based nicotine vaccine
$1,364,701Christopher H Clegg · Tria Bioscience Corporation · UH3 · FY2020 · DA
MACROPHAGES, DENDRITIC CELLS AND PATHOGENS
$1,364,588Carl F Nathan · Weill Medical Coll Of Cornell Univ · P01 · FY2007 · AI
SBIR Phase II: Development of long service life vacuum insulation composites
$1,364,575Saravankumar Shanmugavelayudam · Maxq Research Llc · · FY2015 · TIP
Early Drivers of Humoral Immunity to SARS-CoV-2 Infections
$1,364,482Christopher L King · Case Western Reserve University · U01 · FY2020 · CA
Vaccine Studies Of Simian Immunodeficiency Virus (SIV) in Macaques
$1,364,259Vanessa M. Hirsch · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
Human Respiratory Syncytial Virus Biology And Vaccine Development
$1,364,152Peter Leon Collins · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
Northern New England Clinical and Translational Research Network
$1,364,125Clifford J Rosen · Mainehealth · U54 · FY2023 · GM
San Francisco Bay Clinical Trials Unit
$1,364,094Susan Buchbinder · Public Health Foundation Enterprises · UM1 · FY2015 · AI
Novel Targets for Immunotherapy
$1,363,673Claudia Palena · Division Of Basic Sciences - Nci · ZIC · FY2022 · CA
Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children
$1,363,549Carlos O Esquivel · Stanford University · U01 · FY2016 · AI